Susan Domchek, MD, discussed recent advancements in BRCA-related research. Dr. Domchek is the Basser Center's Executive Director, Basser Professor in Oncology at the University of Pennsylvania, and Director of the Marianne and Robert MacDonald Cancer Risk Evaluation Center.

Basser Executive Director Susan Domchek, MD, discusses the differences between BRCA1 and BRCA2 mutations and explains how the varying risk factors could impact individuals and their families.

There are just a few hours left to join our matching gift challenge and help provide hope to individuals and families with a BRCA1/2 mutation. Make a gift by midnight at basser.org/donate and it will go TWICE as far!

Thanks to the Basser Center, better options for cancer treatment and prevention are on the horizon. Join our matching gift challenge today and help accelerate this life-saving work. Give before December 31st to translate research into cures. Give now at basser.org/donate.

The BFOR study provides genetic testing for common BRCA mutations for women and men of Ashkenazi (Eastern European) Jewish ancestry, age 25 or older, in four U.S. metropolitan areas.

Clinical trials conducted at the Basser Center have been integral to several important FDA approvals of new therapies for patients with BRCA-related ovarian and breast cancers. Help us build on this progress and translate research into cures by joining our matching gift challenge! 

We are so excited to announce our December Matching Gift Campaign! To help accelerate our progress, a generous supporter has pledged to match all gifts to the Basser Center through the end of the year, up to $50,000. Give today at basser.org/donate and SAVE LIVES by translating research into cures. 

Basser Executive Director Susan Domchek, MD, discusses how BRCA mutations impact men, including which cancers they are at hereditary risk for and recommendations for screening.

Basser Executive Director Susan Domchek, MD, discusses BRCA-related ovarian cancer risk and management options, such as recent research into fallopian tube removal.

Basser oncologist Payal Shah, MD, discusses landmark approvals of targeted therapies for the treatment of BRCA-related breast cancer, as well as ongoing cancer research. 

Basser Executive Director Susan Domchek, MD, discusses typical guidelines for follow up to BRCA-related breast cancer.